Not really diffiucult. When monepantel's anti-cancer properties were first studied by professor Morris et al of UNSW back in 2013-14, it became apparent that it was acting as an mTOR inhibitor that was upregulating the autophagy process. As studies proceeded in the neurodegenerative science, it was becoming increasingly clear that one of the problems was a lack of autophagy. So Mollard and Aston of PharmAust put two and two together in regard to the possibility that monepantel could be useful for treating neurodegenerative diseases as well.
- Forums
- ASX - By Stock
- Ann: PharmAust Presentation
Not really diffiucult. When monepantel's anti-cancer properties...
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
19.5¢ |
Change
-0.010(4.88%) |
Mkt cap ! $77.20M |
Open | High | Low | Value | Volume |
19.5¢ | 19.5¢ | 18.8¢ | $250.9K | 1.307M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 574257 | 19.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.5¢ | 47481 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 574257 | 0.190 |
8 | 321172 | 0.185 |
15 | 336099 | 0.180 |
5 | 478321 | 0.175 |
8 | 319529 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.195 | 47481 | 4 |
0.200 | 511857 | 6 |
0.205 | 98515 | 5 |
0.210 | 220000 | 2 |
0.215 | 507775 | 7 |
Last trade - 11.03am 27/06/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |